Breast cancer and malignant female cervical carcinoma
Conditions
Interventions
According to whether there is lymphedema in the treatment of breast cancer, they were divided into group 1: lymphedema group
Group 2: Non lymphedema group:None
Sponsors
Beijing Shijitan Hospital, Capital Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1) Female breast / endometrial cancer / cervical cancer / ovarian cancer; 2)without distant metastasis. 3) No primary cancer in other organs; 4) Not pregnant; 5) Non-inflammatory breast cancer; 6) Standardized treatment (neoadjuvant chemotherapy + surgery + postoperative adjuvant chemotherapy) has been completed in the early stage;
Exclusion criteria
Exclusion criteria: 1) uncertain lymph node status 2) Distant metastasis at initial diagnosis 3) Irregular treatment 4) Primary breast, uterus, cervix or ovarian lymphoma, sarcoma and other special types
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| development of lymphedema; | — |
Secondary
| Measure | Time frame |
|---|---|
| the change of score of life quality ; | — |
Countries
China
Contacts
Public ContactXiaolei Liu
Beijing Shijitan Hospital, Capital Medical University
Outcome results
None listed